Correlation Between Fate Therapeutics and Janux Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Janux Therapeutics, you can compare the effects of market volatilities on Fate Therapeutics and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Janux Therapeutics.
Diversification Opportunities for Fate Therapeutics and Janux Therapeutics
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fate and Janux is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Janux Therapeutics go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Janux Therapeutics
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Janux Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Fate Therapeutics is 1.39 times less risky than Janux Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Janux Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 4,882 in Janux Therapeutics on September 26, 2024 and sell it today you would earn a total of 732.00 from holding Janux Therapeutics or generate 14.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Janux Therapeutics
Performance |
Timeline |
Fate Therapeutics |
Janux Therapeutics |
Fate Therapeutics and Janux Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Janux Therapeutics
The main advantage of trading using opposite Fate Therapeutics and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Janux Therapeutics vs. Fate Therapeutics | Janux Therapeutics vs. Caribou Biosciences | Janux Therapeutics vs. Karyopharm Therapeutics | Janux Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |